Summit Financial Wealth Advisors, LLC - ACTINIUM PHARMACEUTICALS INC ownership

ACTINIUM PHARMACEUTICALS INC's ticker is ATNM and the CUSIP is 00507W107. A total of 44 filers reported holding ACTINIUM PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Summit Financial Wealth Advisors, LLC ownership history of ACTINIUM PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2020$5,000
+66.7%
14,0000.0%0.00%0.0%
Q1 2020$3,0000.0%14,0000.0%0.00%0.0%
Q4 2019$3,00014,0000.00%
Other shareholders
ACTINIUM PHARMACEUTICALS INC shareholders Q4 2019
NameSharesValueWeighting ↓
Sio Capital Management, LLC 1,590,267$915,0000.48%
ARMISTICE CAPITAL, LLC 4,382,000$2,520,0000.30%
DAFNA Capital Management LLC 333,000$192,0000.12%
SABBY MANAGEMENT, LLC 2,434,103$1,400,0000.09%
Anson Funds Management LP 1,024,592$589,0000.09%
Hartford Financial Management Inc. 18,000$10,0000.01%
Summit X, LLC 11,000$7,0000.01%
SNS Financial Group, LLC 18,000$10,0000.00%
DOWLING & YAHNKE LLC 22,870$13,0000.00%
A.R.T. Advisors, LLC 30,005$17,0000.00%
View complete list of ACTINIUM PHARMACEUTICALS INC shareholders